Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Protalix Biotherapeutics (PLX)
- 2.105
- +0.075+3.69%
Trading May 22 15:51 ET
169.60MMarket Cap11.08P/E (TTM)
2.120High2.040Low598.02KVolume2.060Open2.030Prev Close1.25MTurnover0.82%Turnover RatioLossP/E (Static)80.57MShares3.19052wk High2.52P/B153.11MFloat Cap1.32052wk Low--Dividend TTM72.73MShs Float1037.500Historical High--Div Yield TTM3.94%Range %0.700Historical Low2.085Avg Price1Lot Size
Protalix Biotherapeutics (PLX) Key Financial Indicators
PLX Earnings per Share (EPS)
According to the latest financial report of Protalix Biotherapeutics, the latest earnings per share (TTM) for the company is 0.22. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
PLX Free Cash Flow (FCF)
Interested in knowing about Protalix Biotherapeutics's free cash flow? The latest report shows it as 21.26M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
PLX Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Protalix Biotherapeutics shows that the company's current ratio is 3.15, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
PLX Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Protalix Biotherapeutics, the quick ratio is 1.97, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
PLX Return on Equity (ROE)
Want to learn more about the financial health of Protalix Biotherapeutics? The latest ROE figure is 31.73%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
PLX Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Protalix Biotherapeutics, the total asset return on investment (ROA) is 19.84%.
Currency: USD
Quarterly
Loading...
PLX Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Protalix Biotherapeutics's latest financial report to see how their gross margin is doing - currently at 87.77%.
Currency: USD
Quarterly
Loading...
PLX Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Protalix Biotherapeutics, the net profit margin is 54.27%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm